Protect Animal Health Incorporation
TTPEX:785026.80
TWD
-0.40
(-1.47%)
ISIN
TW0007850000
Return %
Stock
S&P 500
1Y
-31.89
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Semi-annual Revenue
FRC
•
in mil. unless spec.Semi-annual Earnings Per Share
FRC
•
in mil. unless spec.Semi-annual Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Hao Lin Song
- Full Time Employees
- 51
- Sector
- Retail trade
- Industry
- Specialty stores
- Address
- Taipei Taiwan
- Website
- protectvac.com
- Similar Companies
- Business
- Protect Animal Health Incorporation operates as an animal healthcare and biotechnology company that engages in the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, biological products, and nutritional health solutions for companion animals and livestock. The company's core offerings encompass veterinary pharmaceutical preparations, including antimicrobial agents, antiparasitic formulations, analgesics, anti-inflammatory therapies, and dermatological medications; veterinary biologicals, including preventive vaccines, therapeutic antibodies, and immunomodulatory agents for livestock, poultry, and pets; animal nutritional supplements and functional feed additives, including probiotic formulations, enzyme complexes, organic acidifiers, and vitamin-mineral premixes designed to optimize gut health and growth performance; and veterinary diagnostic solutions, including rapid test kits, point-of-care diagnostic devices, and clinical testing reagents for early disease screening and health monitoring. Protect Animal Health Incorporation serves veterinary clinics, animal hospitals, commercial livestock and poultry farms, feed mills, and pet care distributors across domestic and regional international markets throughout the Asia-Pacific region. In recent developments, the company initiated trading on the Emerging Stock Board of the Taipei Exchange (TPEX: 7850) to support ongoing clinical research, regulatory filings, and manufacturing scale-up. Within the past two years, the company expanded its current Good Manufacturing Practice (cGMP) production capabilities, entered into strategic research and development alliances with academic veterinary institutes to co-develop novel pet therapeutic biologicals, broadened its commercial distribution network into emerging Southeast Asian agricultural sectors, and introduced a new generation of preventive pet wellness and point-of-care diagnostic product lines. Protect Animal Health Incorporation is headquartered in Taiwan.